Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
8 studies found for:    Open Studies | "Vision, Low"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Vision, Low"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Efficacy of Enhancing Low Vision Mobility Thru Visual Training in Virtual World
Condition: Low Vision
Intervention:
2 Recruiting Living Successfully With Chronic Eye Diseases
Conditions: Chronic Diseases;   Low Vision;   Diabetic Retinopathy;   Glaucoma;   Age-related Macular Degeneration
Intervention: Behavioral: Low Vision Self-Management Program
3 Recruiting Visual and Functional Assessment in Low Vision Patients
Conditions: Retinitis Pigmentosa;   Age-related Macular Degeneration;   Optic Nerve Pathology;   Inherited Retinal Dystrophies
Intervention:
4 Recruiting Electric Stimulation of the Eye to Improve Vision After Trauma
Conditions: Non-arteritic Anterior Ischemic Optic Neuropathy;   Decreased Vision Due to Ocular Trauma
Intervention: Device: Transcorneal Electrical Stimulation
5 Unknown  Clinical Effectiveness of Low Vision Rehabilitation in Glaucoma Patients
Condition: Glaucoma
Interventions: Device: portable CCTV;   Device: Telescopes, telemicroscopes and microscopes;   Device: Absorptive filters
6 Recruiting Ziv-aflibercept in Eyes With Retinal Diseases and Poor Vision-phase I
Conditions: Age Related Macular Degeneration;   Central Retinal Vein Occlusion
Intervention: Drug: ziv-aflibercept drug
7 Not yet recruiting Evaluation of the Distortion Correction Data Collection (DCDC) App Software
Condition: Age-related Macular Degeneration
Intervention: Other: DCDC App
8 Recruiting A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DME
Condition: Diabetic Macular Edema
Intervention: Drug: KVD001 Injection

Indicates status has not been verified in more than two years